A Long-term Trial of OPC-34712 in Patients With Schizophrenia

NCT01456897 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

282

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: OPC-34712

Sponsor

Otsuka Pharmaceutical Co., Ltd.